Dr Karen Mustian of the University of Rochester Medical Center, Rochester, New York, NY gives an overview of cachexia, which is a condition where patients lose over 10% of their muscle mass and/or fat mass, and is associated with functional declines. It puts a patient at high risk for dose reductions, and is a real problem given that it also puts the patient on poor prognosis. It is also very closely associated with fatigue. Recently, there have been studies that suggest that there is a clear role for the use of exercise to treat fatigue and cachexia. It is therefore essential to realize that it is not enough to give patients an agent to stabilize their body mass. Functional impairment and fatigue is still present after treating patients with such agents. In the future, pharmaceutical agents and exercise interventions might be able to stabilize body mass (both lean and fat mass), prevent weight loss, maintain the physical function, and in turn, reduce fatigue. Recorded at the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Ocular Oncology (ISOO) 2016 Annual Meeting on Supportive Care in Cancer held in Adelaide, Australia. This programme has been supported by Helsinn, through an unrestricted educational grant to the Patient Empowerment Foundation. Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe

Related Videos :







How exercise can help with fatigue and cachexia [xBYyvTlTM]

How exercise can help with fatigue and cachexia [xBYyvTlTM]

Dr Karen Mustian of the University of Rochester Medical Center, Rochester, New York, NY gives an overview of cachexia, which is a condition where patients lose over 10% of their muscle mass and/or fat mass, and is associated with functional declines. It puts a patient at high risk for dose reductions, and is a real problem given that it also puts the patient on poor prognosis. It is also very closely associated with fatigue. Recently, there have been studies that suggest that there is a clear role for the use of exercise to treat fatigue and cachexia. It is therefore essential to realize that it is not enough to give patients an agent to stabilize their body mass. Functional impairment and fatigue is still present after treating patients with such agents. In the future, pharmaceutical agents and exercise interventions might be able to stabilize body mass (both lean and fat mass), prevent weight loss, maintain the physical function, and in turn, reduce fatigue. Recorded at the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Ocular Oncology (ISOO) 2016 Annual Meeting on Supportive Care in Cancer held in Adelaide, Australia. This programme has been supported by Helsinn, through an unrestricted educational grant to the Patient Empowerment Foundation. Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe

Related Videos :

Aired: December 3rd 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now